ACILGUANIDINAS
COMPUESTOS DE GUANIDINA DE FORMULA III, TENIENDO X(2) LOS SIGNIFICADOS INDICADOS EN LAS REIVINDICACIONES. SE UTILIZAN EN LA PREPARACION DE MEDICAMENTOS VALIOSOS ANTIARRITMICOS CON COMPONENTES CARDIOPROTECTORES PARA LA PREVENCION DEL INFARTO Y PARA EL TRATAMIENTO DEL INFARTO, ASI COMO PARA EL TRATAMI...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | Spanish |
Published |
01.07.2004
|
Edition | 7 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | COMPUESTOS DE GUANIDINA DE FORMULA III, TENIENDO X(2) LOS SIGNIFICADOS INDICADOS EN LAS REIVINDICACIONES. SE UTILIZAN EN LA PREPARACION DE MEDICAMENTOS VALIOSOS ANTIARRITMICOS CON COMPONENTES CARDIOPROTECTORES PARA LA PREVENCION DEL INFARTO Y PARA EL TRATAMIENTO DEL INFARTO, ASI COMO PARA EL TRATAMIENTO DE LA ANGINA PECTORAL, DADO QUE ELLOS DE MANERA PREVENTIVA INHIBEN O BAJAN MUCHO LOS PROCESOS PATOFISIOLOGICOS CON LA APARICION DE LESIONES INDUCIDAS ISQUEMICAMENTE, EN PARTICULAR LA DESCARGA DE ARRITMIAS CARDIACAS INDUCIDAS ISQUEMICAMENTE. A CAUSA DE SUS EFECTOS PROTECTORES CONTRA SITUACIONES PATOLOGICAS DE HIPOXIA Y DE ISQUEMIA SE PUEDEN UTILIZAR ESTOS COMPUESTOS A CAUSA DE SU INHIBICION DEL MECANISMO DE INTERCAMBIO CELULAR NA + /H + COMO MEDICAMENTO PARA EL TRATAMIENTO DE TODAS LAS LES IONES AGUDAS O CRONICAS ORIGINADAS POR ISQUEMIA, O ENFERMEDADES INDUCIDAS DE MANERA PRIMARIA O SECUNDARIA.
Benzoyl-guanidine derivatives (III) are new. (III) are of formula X2-CO-N=C(NH2)2 X2 = R101 = hydrogen, fluoro, chloro, hydroxy, amino or trifluoromethyl; R102 = hydrogen, fluoro, chloro, bromo, cyano, CqF2qCF3, R13SO2, R14R15NCO, R16CO or R17R18NSO2; R13, R14, R16 and R17 = 1-8C alkyl, 3-4C alkenyl, CnH2n-R20, trifluoromethyl or, except for R13, hydrogen; n = 0 or 1; q = 1-5; R20 = 3-6C cycloalkyl or phenyl, optionally substituted by 1-2 of fluoro, chloro, trifluoromethyl, methyl, methoxy or NR21R22; R21 and R22 = hydrogen or methyl; R104 = 1-8C alkyl, CnH2nR20, trifluoromethyl, (iso)quinolyl, pyrrolyl, pyridyl or imidazolyl (all these rings bonded via carbon or nitrogen and optionally substituted by 1 or 2 fluoro, chloro, trifluoromethyl, methoxy, hydroxy or amino (optionally substituted by 1 or 2 methyl)), R87SO2, R88R89NSO2, or R93-ethynyl; R87 = 1-4C alkyl or trifluoromethyl; R88 = hydrogen, 1-4C alkyl, trifluoromethyl, or (CH2)anR90; an = 0 or 1; R90 and R93 = phenyl, optionally substituted as in R20; R103 = any of a wide range of substituents . The full definitions are given in the DEFINITIONS (Full Definitions) Field. |
---|---|
AbstractList | COMPUESTOS DE GUANIDINA DE FORMULA III, TENIENDO X(2) LOS SIGNIFICADOS INDICADOS EN LAS REIVINDICACIONES. SE UTILIZAN EN LA PREPARACION DE MEDICAMENTOS VALIOSOS ANTIARRITMICOS CON COMPONENTES CARDIOPROTECTORES PARA LA PREVENCION DEL INFARTO Y PARA EL TRATAMIENTO DEL INFARTO, ASI COMO PARA EL TRATAMIENTO DE LA ANGINA PECTORAL, DADO QUE ELLOS DE MANERA PREVENTIVA INHIBEN O BAJAN MUCHO LOS PROCESOS PATOFISIOLOGICOS CON LA APARICION DE LESIONES INDUCIDAS ISQUEMICAMENTE, EN PARTICULAR LA DESCARGA DE ARRITMIAS CARDIACAS INDUCIDAS ISQUEMICAMENTE. A CAUSA DE SUS EFECTOS PROTECTORES CONTRA SITUACIONES PATOLOGICAS DE HIPOXIA Y DE ISQUEMIA SE PUEDEN UTILIZAR ESTOS COMPUESTOS A CAUSA DE SU INHIBICION DEL MECANISMO DE INTERCAMBIO CELULAR NA + /H + COMO MEDICAMENTO PARA EL TRATAMIENTO DE TODAS LAS LES IONES AGUDAS O CRONICAS ORIGINADAS POR ISQUEMIA, O ENFERMEDADES INDUCIDAS DE MANERA PRIMARIA O SECUNDARIA.
Benzoyl-guanidine derivatives (III) are new. (III) are of formula X2-CO-N=C(NH2)2 X2 = R101 = hydrogen, fluoro, chloro, hydroxy, amino or trifluoromethyl; R102 = hydrogen, fluoro, chloro, bromo, cyano, CqF2qCF3, R13SO2, R14R15NCO, R16CO or R17R18NSO2; R13, R14, R16 and R17 = 1-8C alkyl, 3-4C alkenyl, CnH2n-R20, trifluoromethyl or, except for R13, hydrogen; n = 0 or 1; q = 1-5; R20 = 3-6C cycloalkyl or phenyl, optionally substituted by 1-2 of fluoro, chloro, trifluoromethyl, methyl, methoxy or NR21R22; R21 and R22 = hydrogen or methyl; R104 = 1-8C alkyl, CnH2nR20, trifluoromethyl, (iso)quinolyl, pyrrolyl, pyridyl or imidazolyl (all these rings bonded via carbon or nitrogen and optionally substituted by 1 or 2 fluoro, chloro, trifluoromethyl, methoxy, hydroxy or amino (optionally substituted by 1 or 2 methyl)), R87SO2, R88R89NSO2, or R93-ethynyl; R87 = 1-4C alkyl or trifluoromethyl; R88 = hydrogen, 1-4C alkyl, trifluoromethyl, or (CH2)anR90; an = 0 or 1; R90 and R93 = phenyl, optionally substituted as in R20; R103 = any of a wide range of substituents . The full definitions are given in the DEFINITIONS (Full Definitions) Field. |
Author | SCHOLZ, WOLFGANG DR ALBUS, UDO DR KLEEMANN, HEINZ-WERNER DR LANG, HANS-JOCHEN DR WEICHERT, ANDREAS DR CRAUSE, PETER DR |
Author_xml | – fullname: KLEEMANN, HEINZ-WERNER DR – fullname: LANG, HANS-JOCHEN DR – fullname: ALBUS, UDO DR – fullname: WEICHERT, ANDREAS DR – fullname: CRAUSE, PETER DR – fullname: SCHOLZ, WOLFGANG DR |
BookMark | eNrjYmDJy89L5WTgc3T29HEPdfTzdPH0cwzmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxrsFGRoYGFuZGISHGxsSoAQCOZh8d |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
Edition | 7 |
ExternalDocumentID | ES2210872TT3 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_ES2210872TT33 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:20:21 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Spanish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_ES2210872TT33 |
Notes | Application Number: ES19990102583T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040701&DB=EPODOC&CC=ES&NR=2210872T3 |
ParticipantIDs | epo_espacenet_ES2210872TT3 |
PublicationCentury | 2000 |
PublicationDate | 20040701 |
PublicationDateYYYYMMDD | 2004-07-01 |
PublicationDate_xml | – month: 07 year: 2004 text: 20040701 day: 01 |
PublicationDecade | 2000 |
PublicationYear | 2004 |
RelatedCompanies | AVENTIS PHARMA DEUTSCHLAND GMBH |
RelatedCompanies_xml | – name: AVENTIS PHARMA DEUTSCHLAND GMBH |
Score | 2.6022112 |
Snippet | COMPUESTOS DE GUANIDINA DE FORMULA III, TENIENDO X(2) LOS SIGNIFICADOS INDICADOS EN LAS REIVINDICACIONES. SE UTILIZAN EN LA PREPARACION DE MEDICAMENTOS... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | ACILGUANIDINAS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040701&DB=EPODOC&locale=&CC=ES&NR=2210872T3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSU1KNk9OszTRNUtLTdI1MUpL1bVIS7PUNU01SzRPSTFOSgKvzfH1M_MINfGKMI1gYsiE7YUBnxNaDj4cEZijkoH5vQRcXhcgBrFcwGsri_WTMoFC-fZuIbYuarDeMbB7AuwbuzjZugb4u_g7qzk72wIbVX5BtkbAro2FuVGIMTMDK7AVbQFa_eca5gTalFKAXKO4CTKwBQANyysRYmBKLRZm4HSGXbwmzMDhC53vBjKhWa9YhIHP0dnTxz3U0c_TxdPPMViUQdHNNcTZQxdocDzcE_GuwTAnhBgbizGwADv3qRIMCpamianmQPcYJJonmyQagToUoAPPweeCARs_ppIMUrjNkcInKc3ABVllAlpaKsPAUlJUmioLrEBLkuTAXgcAGVxyLg |
link.rule.ids | 230,309,786,891,25585,76894 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSU1KNk9OszTRNUtLTdI1MUpL1bVIS7PUNU01SzRPSTFOSgKvzfH1M_MINfGKMI1gYsiE7YUBnxNaDj4cEZijkoH5vQRcXhcgBrFcwGsri_WTMoFC-fZuIbYuarDeMbB7AuwbuzjZugb4u_g7qzk72wIbVX5BtkbAro2FuVGIMTMDK7CFbQk6Zt81zAm0KaUAuUZxE2RgCwAallcixMCUWizMwOkMu3hNmIHDFzrfDWRCs16xCAOfo7Onj3uoo5-ni6efY7Aog6Kba4izhy7Q4Hi4J-Jdg2FOCDE2FmNgAXbuUyUYFCxNE1PNTU0tDBLNk00SjUAdCtCB5-BzwYCNH1NJBinc5kjhk5Rn4PQI8fWJ9_H085Zm4IKsOAEtM5VhYCkpKk2VBVamJUly4GAAAJ5JdSE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ACILGUANIDINAS&rft.inventor=KLEEMANN%2C+HEINZ-WERNER+DR&rft.inventor=LANG%2C+HANS-JOCHEN+DR&rft.inventor=ALBUS%2C+UDO+DR&rft.inventor=WEICHERT%2C+ANDREAS+DR&rft.inventor=CRAUSE%2C+PETER+DR&rft.inventor=SCHOLZ%2C+WOLFGANG+DR&rft.date=2004-07-01&rft.externalDBID=T3&rft.externalDocID=ES2210872TT3 |